Results 111 to 120 of about 8,456 (180)

Current and Emerging Biologic Therapies for Severe Asthma. [PDF]

Drugs
Cazzola M, Matera MG, Ora J, Calzetta L, Rogliani P.   +4 more
europepmc   +1 more source

Beyond inflammation: alarmins as critical drivers of pulmonary fibrosis. [PDF]

ERJ Open Res
Pianigiani T, Dilroba A, Gambini C, Hernandez-Gonzalez F, d'Alessandro M, Bergantini L, Sellares J, Bargagli E, Cameli P.   +8 more
europepmc   +1 more source

Keratinocytes: A key player in skin immunity and their emerging roles in secondary lymphedema. [PDF]

JID Innov
Chen X, Kuonqui K, Pal S, Shin J, Stull-Lane A, Ashokan G, Hespe G, Mehrara BJ, Kataru RP.   +8 more
europepmc   +1 more source

First-in-human, phase 1 study of CM512, a TSLP/IL-13 bispecific antibody, in healthy volunteers: safety, tolerability, pharmacokinetics, pharmacodynamics, and immunogenicity. [PDF]

Front Immunol
Cheng Y, Liu Q, Li M, Xie Y, Men Y, He M, Wang H, Feng X, Zeng M, Zhang L, Chen B, Li J, Feng P.   +12 more
europepmc   +1 more source

Cycling biologic therapy with tezepelumab and mepolizumab for eosinophilic otitis media and eosinophilic pneumonia in a patient with asthma. [PDF]

J Allergy Clin Immunol Glob
Matsuno O, Kawashima K, Hanada Y, Wibowo T, Ishida Y, Ogata A.   +5 more
europepmc   +1 more source

Predictive value of serum interleukin-33 and thymic stromal lymphopoietin for the risk of acute exacerbation in patients with chronic obstructive pulmonary disease. [PDF]

Front Med (Lausanne)
Yin S, Xu K, Wu S, Liu H, Ding Z.
europepmc   +1 more source

Enarodustat suppresses thymic stromal lymphopoietin expression via hypoxia-inducible factor-mediated c-Jun N-terminal kinases dephosphorylation. [PDF]

PLoS One
Segawa R, Yagisawa M, Miyata C, Hirasawa N.   +3 more
europepmc   +1 more source

The Role of Thymic Stromal Lymphopoietin (TSLP) in Eosinophilic Chronic Rhinosinusitis

Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology)
Mamoru Yoshikawa, Tsuguhisa Nakayama, Tetsuji Takabayashi, Tadataka Yabuta, Kenji Kondo   +4 more
openaire   +1 more source

The emerging role of anti-thymic stromal lymphopoietin monoclonal antibody (Tezepelumab) in comorbid and non-comorbid CRSwNP patients: a scoping review. [PDF]

Braz J Otorhinolaryngol
Moffa A, de Corso E, Nardelli D, Loperfido A, Galli J, Baptista P, Casale M.   +6 more
europepmc   +1 more source

The predictive value of combined detection of serum IL-33, TSLP and eosinophils in the treatment effect and exacerbation risk of chronic obstructive pulmonary disease. [PDF]

BMC Pulm Med
Xu J, Wang Y, Gu H, Chen X.
europepmc   +1 more source